Nicholas Deliyanakis
European Commission
DG Research - G4 : Nano S&T and Converging Science and Technologies http://cordis.europa.eu/nanotechnology/ nicholas.deliyanakis@ec.europa.eu
Disclaimer: Note that this presentation is not legally binding and does not represent any commitment on behalf of the European Commission

Medicine and
Health
Information
Technology
Energy
Production /
Storage
Materials
Science
Food, Water and the
Environment
Instruments
Drug delivery GMR Hard
Disk
Hydrogen
Fuel Cells
Lightweight and strong
Remediation methods
Tunneling microscopy
•
•
Potential to serve society by addressing important problems to support industrial competitiveness

 More knowledge
 Research
 Infrastructures
 Education
 Capacity of application
 Innovation
 Patents
 Regulation some issues are better addressed at local, national,
EU or global level
 Reliability
 Metrology
 Standards
 Risk assessment
 Societal acceptance
 Balance and perception of risks and benefits
 Conformity to ethical principles
 Expected response to society needs, to people’s expectations and concerns

Nanosciences and Nanotechnologies:
An Action Plan for Europe 2005-2009 http://cordis.europa.eu/nanotechnology/actionplan.htm
Actions to be implemented by Commission and Member States for integrated, safe and responsible policy:
1.
Research & Development
2.
Infrastructures
3.
Human Resources
4.
Industrial Innovation
5.
Integrating the Societal Dimension
6.
Public Health, Safety, Environmental and Consumer
Protection
7.
International Co-operation
8.
Co-ordination of activities

More than 1.3 billion Euro in more than 550 projects
Infrastructures
40
NEST
22
SME
17 other
36
Health
65
Marie Curie
151
NMP
572
IST
466
EC funding by FP6 programme, M €

Global figures for 2005 M$ ( 1€ ~ 1.25$ )
4000
3500
3000
2500
2000
1500
1000
500
0
1060
2000
450
1380
1250
590
EU
2004
~8 Billion $
US
1700
1000
Japan
Private
States
EC / US federal
400
700 others
2005
~10.5 Billion $
Source: EC, Lux Research

Examples of FP6 projects NMP FP6 projects, e.g.
•CANAPE: Carbon Nanotubes for Applications in Electronics, Catalysis, Composites and
Nano-Biology – University of Cambridge (UK)
•NAIMO:
Nanoscale Integrated processing of self-organizing Multifunctional Organic
Materials Université Libre de Bruxelles (BE)
•NANOFUN-POLY: Nanostructured and functional polymer-based materials and nanocomposites - Consorzio Interuniversitario Scienza e Tecnologia dei Materiali (IT)
•RADSAS: Rational Design and Characterisation of Supramolecular Architectures on
Surfaces Eidgenössische Materialprüfungs- und Forschungsanstalt (CH)
•BIOMACH: Molecular Machines - Design and Nano-Scale Handling of Biological Antetypes and Artificial Mimics Forschungszentrum Karlsruhe GmbH (DE)
•Cornea engineering: Three-dimensional reconstruction of human corneas by tissue engineering” Centre National de la Recherche Scientifique / Rhône Alpes (FR)
•Ambio: Advanced nanostructured surfaces for the control of biofouling University of
Birmingham (UK)
•ANVOC: Application of nanotechnologies for separation and recovery of volatile organic compounds from waste air streams – S&T Research Council of Turkey (TR)
•NANOSAFE2: Safe production and use of nanomaterials Commissariat à l'Energie
Atomique (FR)
•Nanologue: Facilitating dialogue between research, business and the civil society to improve the quality of life, create wealth and reduce impacts to society - Wuppertal Institute for
Climate, Energy and the Environment (DE)

Examples of FP6 projects addressing impact
NANOTOX
IMPART
NANOSAFE2
PARTICLE RISK
POLYSOA
ANTISTORM
DIPNA
CELLNANOTOX
NANOSH
SAPHIR
NANOINTERACT www.impart-nanotox.org
www.nanosafe.org
www.iom-world.com/particlerisk polysoa.web.psi.ch
antistorm.isac.cnr.it
Total Funding for EHS in FP6 ~25 M €

CO-OPERATION
-Health
-Food, Agriculture and Biotechnology
Information and Communication Technologies
Nanosciences, Nanotechnologies, Materials and new Production Technologies
-Energy
-Environment (including Climate Change)
-Transport (including Aeronautics)
-Socio-economic Sciences and Humanities
-Space
-Security
IDEAS (European Research Council)
PEOPLE
CAPACITIES
JRC
4097
32413
6100
1935
9050
1751
3475
2350
1890
4160
623
1430
1400
7510
4750

th
New features of FP7 include:
 Longer duration (7 years)
 Large increase in annual budget (from ~4,500 to ~7,000M €)
 Integration of International Co-operation into all four programmes
 Simplification of operation
 Focus on developing research that meets the needs of
European industry, through the work of Technology
Platforms and the new Joint Technology Initiatives
 Establishment of a European Research Council, funding
European research on the sole basis of excellence

• More than 50 activities in the calls opened in 2007 are directly relevant
• Many more activities are indirectly relevant (e.g. in Health)
• 300-400M € estimated in 2007
• Doubling of the FP6 funding expected over duration of FP7
Nanoscience
NMP-2007-1.1-1
CP
NMP-2007-1.1-2
CP
NMP-2007-1.1-3
CSA
Nano-scale mechanisms of bio/non-bio interactions
Self-assembling and self-organisation
NMP-2007-1.1-4
CSA
NMP-2007-1.1-5
CSA (ERANET)
Support to ICPC researchers in nanotechnology and creation of a free and open electronic archive of nanosciences and nanotechnologies scientific and technical publications
Development of methodology, collection and elaboration of scientific-technical and socio-economic data and studies on nanosciences and nanotechnologies, including risk assessment, and establishment of an observatory
ERANET Plus in nanosciences

Technology development
NMP-2007-1.2-1
Large CP
NMP-2007-1.2-2
SME-targeted CP
NMP-2007-1.2-4
CSA
NMP-2007-1.2-5
CSA
NMP-2007-3.4-1
SME-targeted CP
NMP-2007-3.5-1
Large CP
NMP-2007-3.5-2
Large CP
NMP-2007-4.0-2
SME-targeted CP
Pilot lines to study, develop and up-scale nanotechnologybased processes from laboratory
Equipment and methods for nanotechnology
Coordination in nanometrology
Examining capacity building in nanobiotechnology
Rapid Manufacturing Concepts for Small Series Industrial
Production
Processes and Equipment for High Quality Industrial
Production of 3-Dimensional Nanosurfaces
Production Technologies and equipment for Micro-
Manufacturing
Application of new materials including bio-based fibres in high-added value textile products

Impact assessment and societal issues
NMP-2007-1.3-1
Large CP
NMP-2007-1.3-2
CP
NMP-2007-1.3-3
CSA
NMP-2007-1.3-4
CSA
NMP-2007-1.3-5
CSA
HEALTH-2007-
1.3-4
CP
SiS-2007-1.2.3.2-
CT
CSA
Specific, easy-to-use portable devices for measurement and analysis
Risk assessment of engineered nanoparticles on health and the environment
Scientific review on the data and studies on the potential impact on health, safety and the environment of engineered nanoparticles
Creation of a critical and commented database on the health, safety and environmental impact of nanoparticles
Coordination in studying the environmental, safety and health impact of engineered nanoparticles and nanotechnology based materials and products
Alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics
Science in Society: Nanoscience and Nanotechnology

Nanomaterials
NMP-2007-2.1.1
Large CP
NMP-2007-2.1.2
CP
NMP-2007-2.1.3
CSA
NMP-2007-2.2-1
Large CP
NMP-2007-2.2-2
CP
NMP-2007-2.2.-3
CP
NMP-2007-2.4-2
CP
Nanostructured polymer-matrix composites
Nanostructured coatings and thin films
Characterisation of nanostructured materials
Organic materials for electronics and photonics
Nanostructured materials with tailored magnetic properties
Advanced material architectures for energy conversion
Nanostructured catalysts with tailor-made functional surfaces
Renewable materials for functional packaging applications NMP-2007-2.4-3
CP
NMP-2007-2.5-2
CP
Modelling of microstructural evolution under work conditions and in materials processing

Nanomaterials –cont’d
ENERGY-2007.1.2.4
CP
Novel nanostructured materials for hydrogen storage
ENERGY-2007.1.1.1
CP
Basic research for materials and processes for Polymer
Electrolyte Membrane Fuel Cells (PEMFC)
ENERGY-2007.1.1.2
CP
Basic research on materials and processes for High
Temperature Fuel Cells (SOFC & MCFC)
New materials and processes for advanced electrolysers ENERGY-2007.1.2.1
CP
ENERGY-2007.1.2.2
CP
New materials and processes for advanced multi-fuel processors
AAT-2007.1.1.2
CP, CSA
Aerostructures
Nanoelectronics
ICT-2007.3.1
CP, NoE, CSA
ICT-2007.8.1
CP, CSA (CA only)
Next generation nanoelectronics components and electronics integration
Nano-scale ICT devices and systems

Nanomedicine
NMP-2007-4.0-4
Large CP
Substantial innovation in the European medical industry: development of nanotechnology-based systems for in-
vivo diagnosis and therapy (in coordination with topics
HEALTH-2007-2.4.1-7 and HEALTH-2007-1.2-3)
Improving targeted drug delivery to cancer cells for cancer therapeutics other than gene therapy
HEALTH-2007-2.4.1-
7
CP
HEALTH-2007-1.2.3
Large CP
NMP-2007-2.3.-1
Large CP
NMP-2007-1.2-3
CSA
ICT-2007-5.1
Large CP, CSA
HEALTH-2007-1.4.4
Large CP 2 nd call
Novel targeted imaging probes for early in vivo diagnosis and/or evaluation of response to therapy
Highly porous bioactive scaffolds controlling angiogenesis for tissue engineering
Analysis of the ethical, regulatory, social and economic environment of nanomedicine
Personal Health Systems for Monitoring and Point-of-Care diagnostics
Development of emerging gene therapy tools and technologies for clinical application
NB: Many more activities in the Health theme are relevant to nanomedicine, e.g. imaging, stem cells and translating research for human health

Other Important Topics
ICT-2007.3.6
CP, NoE, CSA 2 nd call
Micro/nanosystems
Photonic components and subsystems ICT-2007.3.5
CP, NoE, CSA 2 nd call
ICT-2007-C
CP, CSA (CA only)
AAT-2007.6.1.4
CP, CSA
KBBE-2007-2-3-04
CP
KBBE-2007-2-4-04
CP
KBBE-2007-2-5-02
CP
FET (Future and Emerging Technologies) Open
(Open call for bottom-up activities)
Life-cycle
[of air vehicles, including increased use of nanotechnologies]
Nano-devices for quality assurance, food safety and product properties
Innovative and safe packaging
Converging technologies and their potential for the food area
Please consider also opportunities within
COST actions (funding for co-ordination activities) http://www.cost.esf.org/

Human Resources
PEOPLE-2007-1-1-
ITN
Marie Curie Initial Training Networks
(all research areas)
PEOPLE-2007-5-2-
Awards
Marie Curie Awards
(all research areas)
Please consider also the opportunities in educational programmes managed by DG EAC http://ec.europa.eu/education/programmes/programmes_en.html
Ideas – European Research Council
ERC-2007-StG ERC Starting Independent Researcher Grants
(all research areas)
Expected in 2 nd call
ERC Advanced Investigator Grants
(all research areas)
Infrastructures & SMEs
INFRA-2007-
2.2.1.27
Combination CP/CSA
FP7-SME-2007-1
PRINS, Pan-European Research Infrastructures for Nano-
structures (from 2006 ESFRI Roadmap)
Research for the benefit of SMEs

Infrastructures actions a) Optimising the use and development of the best research infrastructures existing in Europe
Co-ordinated calls dedicated to nanotechnology are envisaged b) Pooling of resources (national, private, European) to support the emergence of new facilities required by the scientific community within the next 10-20 years
-European Strategy Forum on Research Infrastructures
(ESFRI): http://www.cordis.europa.eu/esfri/
-Integration through Networks of Excellence

Human Resources actions a) Workshop on research training in N&N, 14-15 April
2005 cordis.europa.eu/nanotechnology/src/educationworkshop.htm b) Educational programmes (Erasmus Mundus, Socrates-
Erasmus) e.g. Erasmus Mundus Masters course in N&N c) Nanotechnology Award (ongoing discussions with
Science and Society directorate) d) Joint initiatives with Marie Curie actions in FP7 are envisaged

Industrial Innovation actions a) Better co-operation between industry and R&D organisations, encouragement of entrepreneurship
 NanoForum, a European N&N gateway www.nanoforum.org
 NanoRoadSME, NanoRoadmap projects
 Exploitation Strategy Seminars
 Risk-Sharing Finance Facility (RSFF)
 Competitiveness and Innovation Programme (CIP) b) Increased involvement of industry in EU R&D projects, in particular of SMEs
 3 Integrated Projects dedicated to SMEs

Industrial Innovation actions c) Digital N&N library
 Implementation by a support or coordination action in
FP7 d) Pre-normative R&D and metrology for nanotechnology
 Two projects in NMP, Nano-Strand and Nanotransport; also addressed in IST e) Patent systems
 Cooperation with EPO Working Group on
Nanotechnology e.g. patent regime, patent analysis, expert exchange, patent monitoring

Industrial Innovation
Patents:
•In 500 FP5 projects (Growth Programme), an average of
0.9 patents per projects were applied for and 0.4 were granted.
•In FP6 so far (sample of 35 projects), about 3 patents per project have been (or will be) filed
• ~45% from IPs
• ~55% from STREPs
• Most patents in: Nanobiotechnology, esp. nanomedicine, self-assembly, nanotubes, organic electronics, sensors and instruments

Societal Dimension actions
ADDRESSING EXPECTATIONS AND
CONCERNS: A real partnership between science, society and policy is a key element of governance: Open dialogue with open results.
a) Ethical reviews of projects carried out, where needed b) European Group of Ethics is assessing Nanomedicine
(opinion in autumn 2006)

Societal Dimension actions c) Studies and foresight activities
 NanoRoadSME project www.nanoroad.net
 NanoRoadMap project www.nanoroadmap.it
d) Social dialogue undertaken through funded projects and events
 Nanologue project www.nanologue.net
 Nanodialogue project www.nanodialogue.org
 “Communicating Science, A survival kit for
Scientists” ec.europa.eu/research/science-society/ pdf/communicating-science_en.pdf
e) Publicity material in many languages http://cordis.europa.eu/nanotechnology/src/pressroom.ht
m

International Cooperation actions a) Declaration or “code of good conduct” – dedicated international dialogue (global meetings in Alexandria (US),
2004, Tokyo, 2006, and Brussels, 2007) b) Issues of mutual benefit - (i) a new ISO group is operational, (ii) OECD is becoming increasingly active and
(iii) a co-ordinated EU/USA call for proposals in
(eco)toxicology is being negotiated c) Database of publications: Addressed in the first FP7 call for proposals




The Commission seeks international debate on nanotechnology-related issues such as public health, safety, environment, consumer protection, risk assessment, metrology, norms, …;

The EU R&D programmes are open to the
World; Europe even funds research teams in
Third Countries;
Europe promotes the monitoring and sharing at international level of information related to the scientific, technological, economical & social development of nanotechnology;
Europe strives for an international “code of conduct” for the responsible development of nanotechnology, and to avoid a “nano-divide”.

Main International Fora and Initiatives on Nanotechnology
ISO, IEEE, Int. Comm.
Weights & Measures standardisation, metrology
Observatory ?
G8 Carnegie Group
World Economic Forum
OECD
Global Science Forum World Social Forum
Global (informal) governmental dialogue on responsible nanotechnology incl. governance & societal dialogue
OECD NESTI nanotechnology indicators
Meridian Inst.,
UNIDO, NEPAD against « divide »
OECD JM CHEMICALS
WP safety nanomaterials characterisation, metrology, toxicity, …
UNESCO ethics incl. risk assessment
APEC, ANF, NEPAD macro-regions
OECD CSTP proposed WP on nanotechnology
IRGC, ICON about risks industry-led
INC industry-led

Co-ordination actions a) Creation of a Commission Interservice Group to monitor and oversee the implementation of the Action Plan, see cordis.europa.eu/nanotechnology/src/contacts.htm
 It is important to have a regular interaction with Member States
(currently: Council Research working party; a “nano” group for international cooperation; and groups for regulation) b) Reporting : We plan to issue a report at the end of 2007 and one at the end of 2009 c) Activities to foster beneficial applications: addressed in proposals for FP7 calls for proposals

Inter-institutional activity
The Commission’s approach has received strong support from
 Council of Ministers
(European Strategy on Nanotechnology)
 European Economic and Social Committee
–Opinion CESE 582/2006
 European Parliament
–Resolution (2006)392, Sep 06

http://cordis.europa.eu/nanotechnology/src/eu_funding.htm
FP7: http://cordis.europa.eu/fp7/home_en.html
FP7 calls: http://cordis.europa.eu/fp7/dc/index.cfm
Nanotechnology homepage: http://cordis.europa.eu/nanotechnology/
Nanosciences and Nanotechnologies:
An Action Plan for Europe 2005-2009 http://cordis.europa.eu/nanotechnology/actionplan.htm
Additional information on nanotechnology: